Arkema SA (OTCMKTS:ARKAY – Get Free Report) saw a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 705 shares, a growth of 68.7% from the July 30th total of 418 shares. Based on an average daily volume of 1,111 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.0% of the company’s stock are short sold.
Arkema Stock Up 1.9%
Shares of OTCMKTS:ARKAY opened at $70.49 on Tuesday. The business’s 50 day moving average is $66.68 and its 200 day moving average is $68.32. Arkema has a 12-month low of $56.28 and a 12-month high of $79.36. The stock has a market cap of $5.36 billion, a price-to-earnings ratio of 243.07 and a beta of 0.85. The company has a quick ratio of 1.64, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The basic materials company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.12. Arkema had a return on equity of 4.27% and a net margin of 0.67%.The business had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.86 billion. On average, sell-side analysts forecast that Arkema will post 3.68 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on ARKAY
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
See Also
- Five stocks we like better than Arkema
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
